Dean Welsch

USPTO Granted Patents = 20 (Patent Applications = 7)

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 29(Granted Patents)

Company Filing History:

20 out of 40

Biomed Valley Discoveries, Inc.

patents

5 out of 1,149

Vertex Pharmaceuticals, Inc.

patents

3 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

4. 1 out of 1,215

The United States of America As Represented by the Department of Health

patents

5. 1 out of 97

Albany Molecular Research, Inc.

patents

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

20 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12187698 - Crystalline forms of CHClNO (2025-01-07),

2. 12076324 - Cancer treatments using combinations of CDK and ERK inhibitors (2024-09-03),

3. 11851498 - Anti-CD276 antibodies (B7H3) (2023-12-26),

4. 11679112 - Cancer treatments using combinations of CDK and ERK inhibitors (2023-06-20),

5. 11390600 - Crystalline forms of CHClNO (2022-07-19),

6. 11246859 - Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers (2022-02-15),

7. 11135225 - Cancer treatments using combinations of CDK and ERK inhibitors (2021-10-05),

8. 11013743 - Cancer treatments using combinations of CDK and ERK inhibitors (2021-05-25),

9. 11007184 - Cancer treatments using combinations of type 2 MEK and ERK inhibitors (2021-05-18),

10. 11007183 - Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors (2021-05-18),

11. 10881646 - Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers (2021-01-05),

12. 10738027 - Crystalline forms of CHClNO (2020-08-11),

13. 10668055 - Cancer treatment using combinations of ERK and RAF inhibitors (2020-06-02),

14. 10604582 - Anti-CD276 antibodies (B7H3) (2020-03-31),

15. 10196443 - TEM8 antibodies and their use in treatment and detection of tumors (2019-02-05),

Title: Dean Welsch: Pioneering Inventor from Parkville

Introduction: Dean Welsch is a distinguished inventor hailing from Parkville, Missouri. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: Dean Welsch holds several patents in various technological domains, including advancements in renewable energy systems, smart home devices, and medical equipment. His recent patents focus on enhancing user experience and improving efficiency in everyday tasks.

Career Highlights: Throughout his illustrious career, Dean Welsch has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. His inventions have garnered acclaim for their practicality and impact on society, earning him a reputation as a forward-thinker in the industry.

Collaborations: Dean Welsch has collaborated with leading tech companies and research institutions to bring his inventions to life. His partnerships have been instrumental in turning his visionary ideas into tangible products that have the potential to shape the future of technology.

Conclusion: Dean Welsch's relentless pursuit of innovation and his commitment to creating solutions that make a difference have solidified his position as a trailblazing inventor in Parkville and beyond. His contributions to the world of technology continue to inspire and drive progress in the ever-evolving landscape of invention.

This text is generated by artificial intelligence and may not be accurate.